Division of Regulatory Science Project Promoting Clinical Trials for Development of New Drugs


Key Fields Drug Discovery & Development(1st)
R&D phase Nonclinical Study/Pre-clinical Study, Clinical Trials, Clinical Research, None
Division of Regulatory Science, Department of Innovative Drug Discovery and Development
E-mail: rinsho-crt"AT"amed.go.jp
※Replace"AT"with @.

This program aims to develop fundamental research in Japan and transform it into pharmaceutical approvals and create innovative drugs. It promotes nonclinical studies, which properly bridge basic research with clinical trials; high-quality research, such as clinical research based on science and ethics that are highly likely to be sufficiently guaranteed; and research that aims to improve the state of clinical research and clinical trials.

Management and Evaluation Framework

PS (Program Supervisor)
  • Yoichi Nakanishi, M.D., Ph.D., President, Kitakyushu City Hospital Organization
PO (Program Officer)
  • Norihiro Sato, M.D., Ph.D., Deputy Director, Hokkaido University Hospital / Professor, Director, Clinical Research and Medical Innovation Center
  • Koh Nakata, M.D., Ph.D., Project Professor, Division of Pioneering Advanced Therapeutics Niigata University Medical & Dental Hospital

Last updated 05/01/20